Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight
Michael Javaheri, MD; Carolyn Majcher, OD, FAAO, FORS
Release Date: July 15, 2024
Expiration Date: July 15, 2025
Activity Overview
This online, on-demand virtual event brings together renowned experts in neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). In this educational program, these experts review the evidence for extended-interval treatment of nAMD and DME with newer anti-VEGF therapies and discuss multidisciplinary care of patients with nAMD or DME with comanagement between ophthalmologists and optometrists.
This educational activity is an archive of the live virtual event held on June 27, 2024.
Target Audience
This activity will have a target audience of retina specialists, ophthalmologists, and optometrists.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Formulate an effective multidisciplinary approach between retina specialists, optometrists, and ophthalmologists to improve the overall management of retinal diseases
- Develop treatment plans for patients recently diagnosed nAMD
- Develop treatment plans for patients recently diagnosed with DME
Michael Javaheri, MD
Ophthalmologist
Cedars-Sinai Medical Center
Beverly Hills, CA
Disclosures: Michael Javaheri, MD, has no relevant financial relationships with ineligible companies.
Carolyn Majcher, OD, FAAO, FORS
Associate Professor
Director, Residency Programs
Oklahoma College of Optometry
Tahlequah, OK
Disclosures: Consultant: Apellis, Astellas, LENZ Therapeutics, Notal Vision, Optomed, Regeneron, Tarsus, Topcon, Zeiss; Speakers’ Bureau: Apellis, Astellas, Optomed, Regeneron, Zeiss.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.